Erweiterte Suche

Heinrich Hiesinger ist ein deutscher Unternehmer, der an der Spitze von 7 verschiedenen Unternehmen stand und derzeit die Position des Aufsichtsratsvorsitzenden der thyssenkrupp Steel Europe AG innehat. Außerdem ist er Mitglied des Vorstands der Deutschen Post AG, der Bayerischen Motoren Werke AG und der Fresenius Management SE. In der Vergangenheit war er Vorsitzender des Aufsichtsrats der TK Elevator GmbH, Vorsitzender des Vorstands der ThyssenKrupp AG und Vorsitzender der Thyssenkrupp (China) Ltd. (eine Tochtergesellschaft der ThyssenKrupp AG) und Chief Executive Officer-Industry Sector der Siemens AG Vorsitzender des Aufsichtsrats der Siemens Schweiz AG, President & Chief Executive Officer der Siemens Building Technologies AG und President der Siemens Industry, Inc. (alles Tochtergesellschaften der Siemens AG). Heinrich Hiesinger hat an der Technischen Universitt Mnchen studiert, promoviert und einen Hochschulabschluss erworben.

Heinrich Kolem worked as the President-Advanced Therapies at Siemens Healthineers AG from 2015 to 2018.

Heinrich Schlieker ist Senior Vice President-Technical Operations bei SAGE Therapeutics, Inc. Dr. Schlieker hatte zuvor die Position des VP-Process Development & Manufacturing bei Cubist, Inc. inne. Dr. Schlieker erhielt einen Doktortitel und einen Bachelor-Abschluss von der Technischen Universitt Braunschweig.

Mr. Daniel Heinrich Grieder is an Independent Non-Executive Director at Rieter Holding AG, a Chief Executive Officer at Hugo Boss AG and a Chief Executive Officer at The Tommy Hilfiger Group.
He is on the Board of Directors at Rieter Holding AG.
Mr. Grieder was previously employed as a Chief Executive Officer & Director by PVH Europe BV, a Chief Executive Officer by The Tommy Hilfiger Group, a Chief Executive Officer by Tommy Hilfiger Group BV, a Chief Executive Officer by Tommy Hilfiger Europe BV, a Co-Managing Director by CK Stores Germany GmbH, a Managing Director by Hilfiger Stores GmbH, a Founder by Max Trade Service AG, a Co-Managing Director by PVH Deutschland GmbH, and a Chief Executive Officer by Tommy Hilfiger Corp.
(Netherlands).
He also served on the board at Calvin Klein Stores UK Ltd., Hilfiger Stores Ltd.
and PVH UK Ltd.
He received his undergraduate degree from Fachhochschule Ludwigshafen am Rhein.

Herr Heinrich C. Spoerry ist Präsident des Verwaltungsrats der Frutiger AG, unabhängiges, nicht-exekutives Mitglied des Verwaltungsrats der Bucher Industries AG und Präsident des Verwaltungsrats der SFS Group AG. Er ist Mitglied des Verwaltungsrats der Bucher Industries AG, der Industrie- und Handelskammer St. Gallen-Appenzell, der Bucher Hydraulics AG und der Mikron Infrared, Inc. Zuvor war Herr Spoerry als Verwaltungsratspräsident bei der Mikron Holding AG, als Mitglied der Geschäftsleitung bei der Cerberus AG, als Mitglied der Geschäftsleitung bei der Stfa Control System AG und als Präsident bei der Mikron AG tätig. Er war auch Mitglied des Verwaltungsrats der Tegula AG. Er erhielt seinen Abschluss an der Universität St. Gallen und einen MBA am Massachusetts Institute of Technology.

Thomas Heinrich Glanzmann founded Medical Technology Ventures LLC in 2016, where he is working as Partner from 2016 and Medical Technology Venture Partners in 2017, where he is working as Partner from 2017.
Mr. Glanzmann also currently works at Grifols SA, as Executive Chairman from 2024, Grifols, Inc., as Chairman from 2011, Alcon AG, as Independent Director from 2019, Sage Products LLC, as Director, Alcon NV, as Director, and Alcon Vision LLC, as Director.
Mr. Glanzmann also formerly worked at Gambro AB, as President & Chief Executive Officer from 2006 to 2011, HemoCue AB, as Chief Executive Officer from 2005 to 2012, Immuno International AG, as Chief Executive Officer from 1996 to 1998, Gambro Lundia AB, as Chief Executive Officer & President from 2006 to 2011, Plasma Protein Therapeutics Association, as Chairman from 2000 to 2001, Grifols Shared Services North America, Inc., as Chairman, Sulzer AG, as Independent Non-Executive Director from 2012 to 2018, Alkahest, Inc., as Director, Forum Mondial de L'Economie, as Managing Director-Davos Region from 2004 to 2005, Baxter Healthcare Corp., as Senior Vice President from 1998 to 2004, Philip Morris Spain SA, as Country Manager from 1984 to 1988, Baxter BioScience Corp., as President, Baxter AG, as Senior Vice President, and Baxter World Trade Corp., as Senior Vice President.
Mr. Glanzmann received his undergraduate degree from Dartmouth College and Masters Business Admin degree from International Institute for Management Development.

Franz J.
Hiesinger currently works at Mayr-Melnhof Karton AG, as Chief Financial Officer from 2017 and Mondi Packaging AG, as Chief Financial Officer.
Mr. Hiesinger also formerly worked at Europapier International AG, as Director-Supervisory Board and Mondi Swiecie SA, as Member-Supervisory Board.
Mr. Hiesinger received his Masters Business Admin degree from Vienna University of Economics & Business.

Heinrich Schlomann worked as a Director at KfW Mittelstandsbank (Private Equity) from 2011 to 2013.

Heinrich Weiss is currently the Chairman of the Russian-German Chamber of Commerce, Chairman-Management Board of Bernhard-Weiss-Stiftung, Chairman-Supervisory Board of Gottfried Schultz Automobilhandels SE, Co-Managing Director of Siemag Weiss GmbH & Co. KG, Co-Managing Director of Siemag Weiss Verwaltungs GmbH, and a Member-Supervisory Board of Thyssen-Bornemisza Group since 2011.
In the past, he held positions such as Chairman & Chief Executive Officer of SMS GmbH, Chairman-Shareholders Committee of SMS group GmbH, Vice Chairman of Paul Wurth SA, Chairman-Supervisory Board of SMS Holding GmbH, Director of Bombardier, Inc. in 2005, Director-Supervisory Board of Commerzbank AG, Director-Supervisory Board of Voith GmbH & Co. KGaA from 2009 to 2011, Director of the Asia-Pacific Committee of German Business (Germany), Member-Supervisory Board of Deutsche Bahn AG, and Member-Executive Board of DB Mobility Logistics AG from 2011 to 2013.

Heinrich Roman Eisenmann is the founder and Chief Executive Officer of Isodetect GmbH, a company he founded in 2005.
He holds an undergraduate degree from the Swiss Federal Institute of Technology and another undergraduate degree from Universität Konstanz, which he received in 1998.

Heinrich Söfjer worked as a Member-Supervisory Board at Volkswagen AG from 2007 to 2010.

James A.
Heinrich is the founder of Pacific Coast Cosmetic & Laser Medical Center, Inc. (founded in 1999).
He is currently a Director at Mission Hospital Foundation, Director at City of Mission Viejo (California), Director at Beach Cities Commercial Bank, and a Member of the American Academy of Facial & Plastic Reconstruction Surgery.
In the past, he served as an Independent Director at Capital Bank (San Juan Capistrano, California) and was a Partner at Head & Neck Associates of Orange County, Inc. (from 1997 to 2002).
Dr. Heinrich received his undergraduate and doctorate degrees from Loma Linda University.

Mr. Heinrich Wurst is Co-Founder at Hepa Wash GmbH.

John P.
Heinrich is the founder and currently holds the position of Chief Executive Officer & Director at Acuitas Medical Ltd., which was founded in 2006.
He is also currently the Chief Executive Officer at PhoenixNMR since 2014, the Managing Partner at Revolution NMR LLC since 2004, and the Managing Partner at Kansas Analytical Services LLC since 2007.
In his former positions, Dr. Heinrich served as the President & Chief Executive Officer at Otsuka Electronics Usa, Inc. from 1994 to 1999, as an Independent Non-Executive Director at Sensus Healthcare, Inc. from 2012 to 2024, as the President & Chief Operating Officer at Meretek Diagnostics, Inc. from 2001 to 2004, and as the Vice President-MRI Products at Technicare Corp.
He also held the positions of President & Chief Operating Officer at Summit World Trade Corp.
from 1991 to 1994 and President & Chief Operating Officer at Technomed International, Inc.Dr. Heinrich obtained a doctorate degree from the University of Notre Dame.

Heinrich Reimitz is currently a member of the executive board at ECE European City Estates GmbH, a member of Ühinenud Farmid AS, and a member of the management board at HPS Holding GmbH.
Previously, he was a member of the supervisory board at Jenoptik AG, a member of the executive board at S IMMO AG, CEE PROPERTY-INVEST Immobilien GmbH, and Sparkassen Immobilienanlagen AG.
He obtained an undergraduate degree from Vienna University of Economics & Business.

Bob Heinrich is currently the Director at Anchorage Economic Development Corp.
He previously worked as the Director at Anchorage Chamber of Commerce and as the Vice President-Finance at ConocoPhillips Alaska, Inc.

Heinrich Wessels is currently the Chairman-Supervisory Board at Emsländische Volksbank eG.

Heinrich Unger-Krayer is currently the Director at Healthcare Information AG since 2012.
Previously, he held the position of Chief Executive Officer at Novartis Pharma Schweiz AG from 1993 to 1996, Chief Executive Officer at Sandoz International GmbH, Chief Executive Officer at Novartis Norge AS from 1991 to 1992, Director at Interpharma in 2007, Director at the Association of the European Self-Medication Industry in 2005, Director at Dokumed AG in 2009, Training Manager at F.
Hoffmann-La Roche Ltd.
from 1978 to 1982, Head-Pharma Division at Vifor Pharma AG in 1996, Manager-Pharma Division at Merck (Schweiz) AG from 1982 to 1987, Marketing Manager at Sandoz Wander Pharma Schweiz AG from 1987 to 1991.
He also served as a Member-Supervisory Board at AmVac AG, SANOCHEMIA Pharmazeutika GmbH, and e-mediat AG.
Additionally, he was the President of the Association Suisse des Producteurs des Specialitees Grand Pub.
Dr. Unger-Krayer holds a doctorate degree from the University of Basel.

Heinrich Dreismann founded Homestead Clinical Corp., where he worked as Executive Chairman.
Dr. Dreismann also currently works at Apton Biosystems LLC, as Chairman, MOBILion Systems, Inc., as Chairman, Biofidelity Ltd., as Chairman from 2020, and various other companies.
Dr. Dreismann also formerly worked at FasTraq, Inc., as Chief Executive Officer, StageZero Life Sciences Ltd., as Chief Executive Officer, Roche Molecular Systems, Inc., as President & Chief Executive Officer from 2000 to 2006, and various other companies.
Dr. Dreismann received his graduate degree and doctorate degree from the University of Münster.

Mark Heinrich is the founder of Phanfare, Inc. where he holds the title of Chief Technology Officer starting in 2010.
Dr. Heinrich is also the founder of Flashbase, Inc. Dr. Heinrich's former job was as an Associate Professor at the University of Central Florida.
Dr. Heinrich's education includes an undergraduate degree from Duke University in 1991, a graduate degree from Stanford University in 1993, and a doctorate degree from Stanford University in 1998.

Heinrich Wiemer has a current job as a Director at Stichting Oikocredit (Private Equity).

Heinrich Mühlemann is currently the President-Trustees Board at Ypsomed Innovationsfonds.

Jörg Heinrich worked as a Quality Manager at Jenoptik AG from 1991 to 1999.
He was a Member-Supervisory Board at Carl Zeiss Meditec AG from 2011 to 2019.
He also worked as a Product Manager at Spektrum Laser GmbH.

Heinrich Kames has worked as a Member-Supervisory Board at UNIQA Insurance Group AG since 2013.

Heinrich Strenge is currently the Managing Director of Erden- und Kompostwerk Mr. Strenge GmbH & Co. KG and a Member-Supervisory Board of Floragard Beteiligungs.
GmbH.
In the past, he was a Member-Supervisory Council at Olaines kudra.
AS from 2011 to 2013.

Heinrich Stahl is a member of the management board at Korado as, and a member of the supervisory board at VCP Finanz Beteiligungen GmbH, AS Estonian Cell, and VCP Investment Holding AG.
He previously served as a member of the supervisory board at WKB Divestment GmbH and Constantia Flexibles GmbH.
Additionally, he was a member of the supervisory board at Constantia Flexibles AG for a brief period in 2013.

Heinrich Rudi Lenz currently works at Sun Chemical Corp.
(New Jersey), as Vice Chairman from 2019 and DIC Corp., as Executive Officer.
Mr. Lenz also formerly worked at Fairchild Aircraft, Inc., as President & Chief Executive Officer from 2001 to 2002, Sun Chemical Group BV, as President & Chief Executive Officer, Boise, Inc., as Independent Director from 2011 to 2013, AlliedSignal, Inc., as Chief Financial Officer & Vice President-Finance, and Fairchild Aerospace Corp., as Chief Financial Officer & Executive Vice President from 1997 to 2001.
Mr. Lenz received his graduate degree from Hochschule RheinMain.

Mr. Heinrich Lessau is Managing Director-Corporate Finance at Credicorp Capital SA Corredores de Bolsa.
He joined Bice Inversiones in August 2009.
He started his career as a Research Analyst at Santander Investment and became Head of Research in 2000.
Between 2004 to 2006, he was Head of Corporate Finance at Santander Investment.
In 2006, he worked as Chief Executive Officer and Chief Investment Officer at Legg Mason Chile (ex Citicorp Chile).
Following the acquisition of Legg Mason Chile by Banchile, he became Head of Strategic Planning and Marketing Division which he held until August 2009.
He also worked as General Manager by Banedwards Administradora General de Fondos SA. Mr. Lessau holds a degree in Business Administration from Pontificia Universidad Católica and a Master's degree in Business Administration from The Wharton School, University of Pennsylvania.

Heinrich Peters currently works as an Economist at Landesbank Hessen-Thüringen Girozentrale (Broker).

George F.
Heinrich is currently the Vice Chairman & Chief Executive Officer at Foundation Venture Capital Group LLC, the Vice Chairman & Chief Executive Officer at New Jersey Health Foundation, Inc., and a Director at Kayothera, Inc. He previously worked as a Director at Snowdon, Inc. He completed his undergraduate degree at Cornell University and obtained a doctorate from New Jersey Medical School.